Tempo Automation announced its partnership with Blur Product Development to enhance medical device prototyping efficiency. By utilizing Tempo's Accelerated Electronics Manufacturing Platform, Blur aims to shorten product development timelines, crucial for their clients in the medical sector. A comparative project demonstrated Tempo's superior quality, achieving a 0% fallout rate against a 50% fallout with a cheaper competitor. The partnership emphasizes flexibility amid component availability challenges, reinforcing Tempo's commitment to rapid innovation in electronic product development.
Tempo Automation has completed its business combination with ACE Convergence Acquisition Corp., approved on November 17, 2022. The merged entity will operate as Tempo Automation Holdings, Inc., with shares trading on Nasdaq under the symbols TMPO and TMPOW starting November 23, 2022. CEO Joy Weiss expressed excitement about their public journey, aiming to dominate the $290 billion U.S. prototype manufacturing market. The merger enhances Tempo's capability to leverage public market capital for growth in the software-driven PCB prototyping industry.
Tempo Automation has announced its San Francisco factory has received IPC J-STD-001 and IPC-A-610 Class 3 Qualified Manufacturers Listing (QML) qualifications. This requalification solidifies its status as a leading electronics manufacturer, particularly for sectors like aerospace and medical devices. Tempo, recognized since 2019, showcases its compliance with high industry standards and processes. The company’s unique platforms help deliver quality and speed in manufacturing, confirming its capabilities for high-demand applications.
Summary not available.